Avenda Health
PrivateLast Round
Seed Round
Jan 18, 2024
Total Funding Raised
$32.71M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Avenda Health is a healthcare technology company that provides an AI-powered decision support platform, Unfold AI, and a focal laser ablation system to improve the precision of prostate cancer treatment.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Medical Imaging, Precision Medicine, Medical Devices, Healthcare Analytics
Business Model
B2B2C
Customer Profile
Usage-Based SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Avenda Health Comparables
Compare Avenda Health with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Focalyx | 84% | |
| Bot Image, Inc. | 84% | |
| Exact Imaging | 76% |
Avenda Health Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Jan 18, 2024 | ||||
| Series B Extension | Aug 25, 2023 | ||||
| Series B | Aug 25, 2022 | ||||
| Series A | Jul 1, 2019 | ||||
| Angel | Apr 9, 2018 | ||||
Grant | Sep 1, 2017 |
Key People
Founding team and executive leadership
Avenda Health Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| SCP Ventures | Seed Round |
| Plug and Play Tech Center | Series B |
| Wealthing VC Club | Series B |
| VCapital | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 82% MoM.
- Jul 26, 2026
Monthly visitors grew 44% MoM, reaching 1.8K.
Recent news
Latest coverage and updates
- launchesOct 20, 2026
Avenda Health announces Surgery Mode, a suite of intraoperative features that gives surgeons enhanced 3D cancer mapping, MRI review, and capsule risk scores during prostate cancer surgery in California on Oct. 20th '26.
- recognized_asOct 16, 2026
Fierce Healthcare names Avenda Health a finalist in the AI Solutions category on Oct 16th '26.
- adopts_technologySep 17, 2026
Avenda Health deploys Unfold AI at Arizona Urology's three Phoenix-area locations in Arizona, bringing AI-powered 3D prostate cancer mapping to treatment planning on Sep 17th '26.
- signs_new_clientSep 17, 2026
On Sep 17th '26, Arizona Urology Llc adopts Avenda Health's Unfold AI platform across its three Phoenix-area locations in Arizona to support prostate cancer mapping, treatment planning, patient counseling and surgical guidance.
Avenda Health Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Avenda Health's valuation, stock price, and market status.
Is Avenda Health a public or private company?
Avenda Health is a private company.
What is the current stock price of Avenda Health?
Avenda Health is a private company, so its shares have no public market price. Caplight tracks Avenda Health's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Avenda Health worth (valuation)?
Valuation information for Avenda Health is not publicly available.
Can I buy Avenda Health stock?
Avenda Health shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Avenda Health's last funding round?
Avenda Health's most recent funding round was Seed Round on January 18, 2024.
Who are the main investors in Avenda Health?
Key investors in Avenda Health include VCapital.
Will Avenda Health IPO soon?
No public IPO plans have been announced for Avenda Health.
How can I track Avenda Health secondary market activity?
Caplight tracks bids, offers, and trades in Avenda Health's shares on secondary markets.